PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-30 小胖子罗军来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;天然产物小分子
经验分享：2024.01.27投稿
2024.05.14接收
因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。
说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。

3 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-13 ms8000001534909283 来自吉林省

偏重的研究方向：天然产物;炎症
经验分享：2023.11投稿；
2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回；
2023.03.26修回；
2023.05.08 decision in process
2023.05.09 accept
2023.05.11 proof.
从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。

6 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-29 ms6000000875594652 来自江西省

偏重的研究方向：植物药学
经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！

3 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-25 ms8000001555903844 来自北京

请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？

5 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-31 ms8000001555903844 来自北京

大家一般都是几个审稿人呢

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-26 ms8000001555903844 来自北京

这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-25 ms9000000937692960 来自四川省

审稿速度:1.0
偏重的研究方向：中药单体;神经病学
经验分享：3.11投稿
3.15 under review
4.15 revise
5.15 返修回去
目前在等下一步消息

17 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-03-25 ms2000000315947498 来自四川省

1.02投稿，现在还在under review...一点消息无。等的心焦

25 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-29 ms6000000875594652 来自江西省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：植物提取物;生殖
经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2207537, encodeId=4a59220e537b3, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;天然产物小分子 经验分享：2024.01.27投稿 2024.05.14接收 因为是按10分以上杂志设计的课题，因为phar research不接收中药单体，遂无奈改投phytomedicine，小修也在意料之中。 说下大家比较关心的几个问题：1.阳性对照，这个是编辑要求的，我们是补了个细胞实验；2.动物实验要求至少2个浓度，伦理要求比较高：3.WB要求内参和目的条带同一张膜，这个也确实是编辑的要求，但是我们的WB当时做的时候有几个目的条带和内参挨得太近，是不同膜跑的，而且WB太多，不可能再重新做，于是提供了3次的原始数据给编辑，然后诚实说了这个情况，最后编辑给过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Thu May 30 21:32:40 CST 2024, time=2024-05-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2204456, encodeId=69602204456e9, content=偏重的研究方向：天然产物;炎症 经验分享：2023.11投稿； 2024.02.03大修，五个审稿人，审稿人意见不多，编辑给了很多意见，给二十四天，补实验，申请延期一个月修回； 2023.03.26修回； 2023.05.08 decision in process 2023.05.09 accept 2023.05.11 proof. 从投稿到接收发表花了6个月，一审花了接近3个月，杂志要求严格，意见比较中肯，要求提供全膜WB条带（目的条带与内参出自同一条膜），中间因为一些琐事耽搁，2个月后修回，返修后编辑和审稿人效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67c06520855, createdName=ms8000001534909283, createdTime=Mon May 13 15:59:16 CST 2024, time=2024-05-13, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2207182, encodeId=a5f4220e18276, content=偏重的研究方向：植物药学 经验分享：请问大家这样的情况该如何处理：目前已经送审一个多月发送了59条邀请信息但是没有一个专家同意审稿。这样会被拒吗？可不可以推荐审稿人？或者我应该如何处理呢？非常感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:29:34 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2206562, encodeId=4fdc22065622d, content=请问一直在编辑手里没有动静，发邮件催了之后，编辑部回复说编辑正在邀请潜在审稿人，是什么意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sat May 25 19:26:02 CST 2024, time=2024-05-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2207613, encodeId=7c69220e613a4, content=大家一般都是几个审稿人呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Fri May 31 11:53:25 CST 2024, time=2024-05-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206672, encodeId=bfeb22066e242, content=这个期刊Reviewer invited需要多久啊，是有审稿人接受了才会显示under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Sun May 26 11:15:26 CST 2024, time=2024-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206534, encodeId=f2cf220653450, content=审稿速度:1.0 偏重的研究方向：中药单体;神经病学 经验分享：3.11投稿 3.15 under review 4.15 revise 5.15 返修回去 目前在等下一步消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40fb9203247, createdName=ms9000000937692960, createdTime=Sat May 25 13:46:39 CST 2024, time=2024-05-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿，现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207180, encodeId=0ae4220e18080, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：植物提取物;生殖 经验分享：请问大家有没有遇到这样的情况：我已经送审一个多月了发送了50个邀请但是一直没有专家同意审稿，请问我该怎么办呢？会不会有拒稿的风险？可以不可以自己推荐审稿人？拜托了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b868666175, createdName=ms6000000875594652, createdTime=Wed May 29 00:24:21 CST 2024, time=2024-05-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2203518, encodeId=279b2203518d9, content=请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Wed May 08 19:41:40 CST 2024, time=2024-05-08, status=1, ipAttribution=北京)]

2024-05-08 ms8000001555903844 来自北京

请问有遇到过editor assessment这一步开始邮件说是分配给主编，之后又分配给副主编的吗

13 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务